Director- Pharmaceutical Policy and HTA @ (November 2022 - May 2024)
Manager - Policy and Program Development @ (October 2021 - November 2022)
Formulary Management Officer @ (November 2020 - October 2021)
Director, Health Economics and Reimbursement @ (October 2019 - January 2021)
Government Affairs - Ontario @ (September 2017 - October 2019)
Director, Health Economics and Reimbursement @ (May 2015 - August 2017)
Manager, Health Economics and Reimbursement @ (September 2012 - May 2015)
Manager, Health Technology Assessment Analytics @ (October 2011 - September 2012)
Market Access and Pricing Associate Co-op @ (April 2011 - October 2011)
Government and Economic Affairs Associate Co-op @ Eli Lilly and Company (January 2010 - December 2010)
Peter Dyrda Education
McMaster University
MBA (Healthcare Services Management)
2009-2011
McMaster University
B.Sc (Biology & Pharmacology Co-op)
2004-2009
Maastricht University
Doctor of Philosophy - PhD (Health Economics & Policy)
2022
Peter Dyrda Skills
Outcomes Research
Market Access
Health Technology Assessment (HTA)
Health Policy
Health Outcomes
Healthcare
Pharmacoeconomics
Lobbying
Government Relations
Health Economics
HTA
Pharmaceutical Industry
Strategy
Microsoft Excel
Data Analysis
Microsoft Office
Leadership
Program Management
Analytics
Peter Dyrda Summary
Peter Dyrda, based in Toronto, ON, CA, is currently a Director, Pharmaceutical Reviews at Canada's Drug Agency. Peter Dyrda brings experience from previous roles at CADTH and The Janssen Pharmaceutical Companies of Johnson & Johnson. Peter Dyrda holds a 2009 - 2011 MBA in Healthcare Services Management @ McMaster University. With a robust skill set that includes Outcomes Research, Market Access, Health Technology Assessment (HTA), Health Policy, Health Outcomes and more. Peter Dyrda has 2 emails on RocketReach.
Looking for a different Peter Dyrda?
Find contact details for 700 million professionals.